Regenerative Medicine for Osteoarthritis: The Future of Joint Care

Osteoarthritis (OA) is often believed to be the gradual wear and tear of the joint cartilages with aging. Yet, the underlying biology is far more complex. This involves cartilage degeneration, low-grade chronic inflammation, loss of synovial fluid, and modification of the joint environment. Certain early signs involve pain, stiffness, or reduced mobility. 

In terms of joint care, both researchers and clinicians are focusing on adapting to the advanced landscape. With the emergence of Regenerative Medicine for Osteoarthritis, the focus is shifted towards exploring the underlying biology of OA development. The target is to support the body’s natural healing mechanism, reduce inflammation and create a supportive microenvironment. Stem cells are widely investigated to boost cellular communication and release biological signals to influence the joint microenvironment. Thus, stem cell therapy for knee osteoarthritis is widely explored across preclinical and clinical settings. The current article explores the potential of regenerative Medicine in combating OA, improving the joint environment and supporting mobility. 

Ask The Expert

Why Cartilage Replacement Isn’t the Whole Solution?

Cartilage loss is the key feature of OA; however, this isn’t the sole cause. OA involves multiple tissues, including synovium, ligaments, subchondral bone, and surrounding soft tissue. Change in one compartment influences the other’s activities. The key changes in OA potentially include:

• Cartilage has limited repair capacity; it lacks adequate blood supply and consists of fewer chondrocytes
• Extracellular matrix becomes disrupted, influencing chondrocyte function
• Alteration of the subchondral bone and synovial tissue leads to inflammatory responses and mechanical changes in the joint

*NOTE: To address the underlying cause, it is crucial to address tissue maintenance and appropriate cellular activities. Addressing the broader biological perspective is crucial to address the underlying cause of OA development

How do OA Joint Changes?

OA joints have adverse effects on the interconnected network of cartilage, synovial tissue, and subchondral bone. The key changes include:

• Synovium triggers inflammatory signals that influence chondrocyte activities and matrix turnover
• Damaged cartilage releases matrix fragments, it triggers immune responses
• Changes in subchondral bone alter mechanical loading
• The interconnected alteration of the joint environment alters tissue metabolism and mechanical stress

Regenerative Medicine for osteoarthritis in the form of stem cell therapy for osteoarthritis introduces cellular regeneration and involves paracrine signalling. The shift from repairing the single damage to modifying the biological environment of the whole joint potentially can influence the future of OA care. 

How Stem Cells Enter the OA Conversation?

Osteoarthritis stem cell treatments have long heralded to combat OA degeneration. Stem cells potentially differentiate into specific cell types based on the stimulation. Researchers have widely explored mesenchymal stem cells (MSCs) for OA treatment. MSCs possess the unique ability to differentiate into specific cell types (chondrocytes or cartilage cells) and release paracrine signalling. They efficiently stimulate cellular signaling, including combating inflammation, boosting repair mechanisms, and creating a supportive joint microenvironment.  

Stem Cells: Repairers, or Biological Communicators?

The concept of Stem Cell Treatment for Osteoarthritis moves beyond the simplistic idea of new cartilage regeneration. Stem cells undertake multifaceted mechanisms simultaneously. This includes:

• Cellular Regeneration: Some of the MSCs differentiate into specific cell types. This replaces the damaged or dead cells at the affected site
• Boost Repair Mechanism: MSCs release various signalling molecules or cytokines. They boost cellular communication. The body’s natural repair mechanism is elevated.  
• Anti-Inflammation: MSCs release various anti-inflammatory cytokines. They combat the action of pro-inflammatory cytokines, which reduces inflammation  
• Immunomodulation: MSCs modulate the immune response; they calm the joint microenvironment. This is crucial in supporting the action of MSCs and supporting conventional treatment  
• Angiogenesis: MSCs release various growth factors (VEGF, FGFs) that support the formation of tiny blood vessels. This enables the supply of adequate blood, nutrients and oxygen at the injury site [1]

*NOTE: Currently, stem cell therapy for knee osteoarthritis is emerging. The early clinical evidence has indicated a positive trend. In the future, well-structured large-scale clinical trials are required to establish long-term safety and efficacy of the treatment.  

What Does Preclinical and Clinical Evidence Indicate?

The Compilation of Various Clinical Trial Evidence Focused on Osteoarthritis Stem Cell Treatment Indicates:

• Stem Cell Therapy for Osteoarthritis displayed safety and tolerability of stem cells among the subject
• Decrease in pain score following stem cell introduction in comparison with placebo
• Improvement in functional mobility of the patient
• Improvement in the patient’s quality of life
• Reduced inflammation at the target site [1,2]

*NOTE: The current clinical studies did not focus on management of disease progression. The outcome varied among individuals based on various factors including stem cell quality, treatment approach, and individual factors. 

What are the Major Factors for Consideration?

• Use of superior quality, well-characterized stem cells
• Use standardized stem cell isolation and administration procedures
• Consideration of the detailed health assessment of the individuals 
• Consult experienced clinicians and renowned clinics to gain evidence-based information before opting for stem cell treatment for osteoarthritis
• Currently, osteoarthritis stem cell treatments are introduced as a supportive therapeutic regimen with conventional approaches 
• The outcome depends on the stage and severity of the OA, and the individual’s co-morbid condition

*NOTE: Procuring clinical-grade stem cells for regenerative Medicine for osteoarthritis is crucial for treatment success. Advancells, India, is a leading manufacturer and supplier of stem cells for various stem cell conditions. The product comes with a Certificate of Authentication (CoA). 

Could Regenerative Medicine Change the Future of Joint Care?

Regenerative Medicine for osteoarthritis is rapidly evolving into advanced therapeutics that can target the root cause of the disease. Currently, Stem Cell Therapy for Knee Osteoarthritis is at an early stage of clinical application. In future, researchers will focus on the introduction of well-structured, large-scale clinical trials considering multiple parameters. This is crucial to establish long-term safety and efficacy of the treatment. 

References

1. Cao M, Ou Z, Sheng R, Wang Q, Chen X, Zhang C, Dai G, Wang H, Li J, Zhang X, Gao Y. Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Stem cell research & therapy. 2025 Mar 7;16(1):122. 
2. Shoukrie SI, Venugopal S, Dhanoa RK, Selvaraj R, Selvamani TY, Zahra A, Malla J, Hamouda RK, Hamid PF, Selvamani TY. Safety and efficacy of injecting mesenchymal stem cells into a human knee joint to treat osteoarthritis: a systematic review. Cureus. 2022 May 8;14(5). 

FAQ’s

Q- Can Stem Cell Treatment help with Osteoarthritis?

Stem cell-based approaches intend to target the underlying cause. They support the joint environment, reduce inflammatory signalling and improve pain or function. However, results vary, and research is still evolving.

Q- Is Stem Cell Therapy for Knee Osteoarthritis Suitable for Everyone?

No, the suitability of the treatment depends on the severity of osteoarthritis, overall joint health, age and other medical conditions, which can influence whether a regenerative approach is appropriate.

Q- Does Stem Cell Treatment Regrow Damaged Cartilage?

The idea is more complex than simply replacing damaged cartilage with new cells. Researchers are investigating how stem cells and their signalling molecules may influence cartilage, synovial tissue and the surrounding joint environment.

Q- Is Regenerative Medicine for Osteoarthritis Already an Established Treatment?

Regenerative Medicine is a rapidly developing field, but not every stem cell-based approach has the same level of clinical evidence. Some strategies remain under investigation, particularly regarding long-term effectiveness, safety and consistent outcomes.